ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    Clinical and Molecular Significance of Microvascular Inflammation Negative Transplant Glomerulopathy.

    M. Lubetzky,1 N. Hayde,1 P. O Broin,2 Y. Bao,1 E. Akalin.1

    1Montefiore Medical Center, Bronx; 2National University of Ireland Galway University, Galaway, Ireland

    Transplant glomerulopathy (TGP) with donor specific antibodies (DSA) and microvascular inflammation (MVI) is due to chronic antibody mediated rejection (CAMR). We reported previously that intragraft…
  • 2017 American Transplant Congress

    Risk of Kidney Rejection Following Simultaneous Liver Kidney Transplantation.

    S. Shah,1 A. Suddle,1 V. Aluvihare,1 O. Shaw,3 C. Shaw,1 N. Mamode,2 C. Callaghan,2 G. Koffman,2 N. Heaton.1

    1King's College Hospital, London, United Kingdom; 2Guy's and St Thomas' Hospital, London, United Kingdom; 3Viapath, London, United Kingdom

    Introduction: Simultaneous liver kidney transplant (SLK) recipients may be at risk of antibody-mediated kidney rejection (AMR) if the pre-transplant crossmatch is positive (+CXM). Accordingly, in…
  • 2017 American Transplant Congress

    Development of an Anti-HLA Antibody-Producing Humanized Mouse Model.

    S. Yanagawa, H. Tahara, H. Ohdan.

    Hiroshima University, Hiroshima, Japan; Hiroshima University, Hiroshima, Japan; Hiroshima University, Hiroshima, Japan

    Chronic antibody-mediated rejection due to anti-human leukocyte antigen (HLA) antibodies (Abs) is an important problem in organ transplantation. The spleen has been reported to be…
  • 2017 American Transplant Congress

    Utility of Concomitant Biopsy in Simultaneous Pancreas Kidney Transplant Recipients in the Identification of Rejection of Pancreas and Kidney.

    C. Johnson, K. Johnson, B. Kaplan, M. Temkit, R. Heilman, S. Sukumaran Nair, H. Khamash, J. Huskey, G. Mour, H. Chakkera.

    Mayo Clinic Arizona, Phoenix, AZ

    Background: In simultaneous pancreas and kidney transplant (SPKTx) recipients, animal studies suggest concordant rejection rates of 88% (ref: Gruessner et al,1994). Limited information is available…
  • 2017 American Transplant Congress

    Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients.

    S. Seibert,1 D. Schladt,2 B. Wu,3 W. Guan,3 C. Dorr,2,7 D. Berglund,1 R. Remmel,4 A. Matas,5 R. Mannon,6 A. Israni,2,7 W. Oetting,1 P. Jacobson,1 For the DeKAF Genomics Investigators.

    1Dept of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota (UMN), Mpls, MN; 2Chronic Disease Research Group, Minneapolis Medical Research Foundation, Mpls, MN; 3Division of Biostatistics, School of Public Health, UMN, Mpls, MN; 4Dept of Medicinal Chemistry, College of Pharmacy, UMN, Mpls, MN; 5Division of Transplantation, Dept of Surgery, School of Medicine, UMN, Mpls, MN; 6Dept of Nephrology, University of Alabama, Birmingham, AL; 7Dept of Nephrology, Hennepin County Medical Center, School of Medicine, UMN, Mpls, MN

    Background: Poor immunosuppression with tacrolimus (TAC) after kidney transplantation contributes to the development of toxicity and loss of efficacy. We aimed to associate intra-patient TAC…
  • 2017 American Transplant Congress

    Impact of Six-Month Surveillance Biopsies and Monitoring in Pediatric Renal Transplant Recipients.

    J. Lyons,1,2,3 D. Ranch,1,2 R. Hall,1,2,3 P. Maxwell,1,2,3 K. Hitchman,1,2 Y. Hirase,3 B. Crowther.1,2,3

    1University Health System, San Antonio, TX; 2University of Texas Health Science Center San Antonio, San Antonio, TX; 3University of Texas College of Pharmacy, Austin, TX

    Purpose: Evaluate the utility of surveillance biopsies and monitoring 6 months post-transplant.Methods: A retrospective single center chart review of pediatric renal transplant recipients from 01/2011–10/2015…
  • 2017 American Transplant Congress

    Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.

    M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.

    Pediatric Abdominal Transplant, Children's Hospital of Pittsburgh of UPMC, Pittsburgh

    Background: Optimizing immunosuppression requires selecting an agent which can inhibit the dominant anti-rejection mechanism in individual children with liver transplantation (LTx). Extended use of steroids,…
  • 2017 American Transplant Congress

    Endoscopic Ultrasound Guided Biopsy Sampling of the Pancreas Transplant- The Future of Graft Surveillance?

    E. Nordheim,1 V. Paulsen,2 A. Lars,2 R. Horneland,3 K. Brabrand,4 A. Hartmann,1 T. Jenssen.1,5

    1Section of Nephrology, Department of Transplantation, Oslo University Hospital, Oslo, Norway; 2Section of Gastroenterology, Department of Transplantation, Oslo University Hospital, Oslo, Norway; 3Department of Transplantation, Oslo University Hospital, Oslo, Norway; 4Department of Radiology, Oslo University Hospital, Oslo, Norway; 5Metabolic and Renal Research Group, The Arctic University of Norway, Tromsø, Norway

    Background:Pancreas transplantation (PTX) can improve morbidity and potentially increase survival in selected patients with brittle diabetes. Development of a successful and safe biopsy monitoring program…
  • 2017 American Transplant Congress

    Complement Activating Anti-HLA Antibodies: Identification of Specific Histo-Mmolecular Phenotype of Rejection for Complement-Targeting Therapy.

    C. Lefaucheur,1 B. Sis,2 D. Viglietti,1 L. Hidalgo,2 O. Aubert,1 D. Glotz,1 C. Legendre,1 A. Zeevi,3 P. Halloran,2 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2University of Alberta, Edmonton, Canada; 3University of Pittsburgh Medical Center, Pittsburgh

    Addressing the heterogeneity of antibody-mediated allograft rejection by identifying phenotypes based on pathophysiology is critical for improving outcomes in transplantation. We investigated whether complement-binding anti-HLA…
  • 2017 American Transplant Congress

    Maximizing the Potential of Treg-Based Therapies for Transplant Rejection via Computational Immune-Modeling: Effect of Dose, Timing, and Distribution.

    G. Raimondi,1 A. Arun,1 O. Dorabiala,2 J. Arciero.3

    1Plastic & Reconstructive Surgery, Johns Hopkins University, Baltimore; 2Mathematics, Pennsylvania State University, Philadelphia; 3Mathematical Sciences, Indiana University-Purdue University Indianapolis, Indianapolis

    Purpose. Regulatory T cells (Treg), endogenous regulators of the immune system, have a significant therapeutic potential for prevention of transplant rejection. Experimental evidences however, indicate…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences